Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy

Parkinsonism and Related Disorders

Volumn 19, Issue 6, 2013, Pages 590-594

  Giordano, Alfonso ^a,b   Tessitore, Alessandro ^a   Corbo, Daniele ^a   Cirillo, Giovanni ^a   de Micco, Rosa ^a   Russo, Antonio ^a,b   Liguori, Sara ^a   Cirillo, Mario ^a   Esposito, Fabrizio ^c,d   Tedeschi, Gioacchino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b IDC Hermitage Capodimonte   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cerebellar cognitive syndrome; Magnetic resonance imaging; Parkinson's disease; Progressive supranuclear palsy; Voxel based morphometry

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBELLUM; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOLOGIC ASSESSMENT; TEMPORAL CORTEX; THREE DIMENSIONAL IMAGING; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; CASE CONTROL STUDY; COGNITION DISORDERS; COMPLICATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS;

AGED; ATROPHY; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84891519737     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.02.005     Document Type: Article

References (33)

1. Burn D.J., Lees A.J. Progressive supranuclear palsy: where are we now?. Lancet Neurol 2002, 1:359-369.
2. Williams D.R., Lees A.J. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009, 8:270-279.
3. Brown R.G., Lacomblez L., Landwehrmeyer B.G., Bak T., Uttner I., Dubois B., et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010, 133:2382-2393.
4. Canu E., Agosta F., Baglio F., Galantucci S., Nemni R., Filippi M. Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy. Mov Disord 2011, 26:1752-1755.
5. Whitwell J.L., Avula R., Master A., Vemuri P., Senjem M.L., Jones D.T., et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 2011, 17:599-605.
6. Agosta F., Kostić V.S., Galantucci S., Mesaros S., Svetel M., Pagani E., et al. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP parkinsonism: a VBM-DARTEL study. Eur J Neurosci 2010, 32:640-647.
7. Price S., Paviour D., Scahill R., Stevens J., Lees A., Fox N. Voxel based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004, 23:663-669.
8. Kanazawa M., Shimohata T., Toyoshima Y., Tada M., Kakita A., Morita T., et al. Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009, 24:1312-1318.
9. Cordato N.J., Halliday G.M., Harding A.J., Hely M.A., Morris J.G. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000, 47:718-728.
10. Cordato N.J., Pantelis C., Halliday G.M., Velakoulis D., Wood S.J., Stuart G.W., et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002, 125:789-800.
11. Cordato N.J., Duggins A.J., Halliday G.M., Morris J.G., Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005, 128:1259-1266.
12. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
13. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatr 1988, 51:745-752.
14. Emre M., Aarsland D., Brown R. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007, 22:1689-1707.
15. Association A.P. Diagnostic and statistical manual of mental disorder 1994, Washington, DC. 4th ed.
16. Morelli M., Arabia G., Salsone M., Novellino F., Giofrè L., Paletta R., et al. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 2011, 26:527-533.
17. Fahn S., Elton R. Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 153-163. Members of the UPDRS Development Committee, MacMillan, Florham Park, NJ, 293-04. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
18. Factor S.A., Steenland N.K., Higgins D.S., Molho E.S., Kay D.M., Montimurro J., et al. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatr 2011, 82:564-568.
19. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
20. Paviour D.C., Price S.L., Jahanshahi M., Lees A.J., Fox N.C. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006, 21:989-996.
21. Shirota Y., Hamada M., Hanajima R., Terao Y., Matsumoto H., Ohminami S., et al. Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study. Mov Disord 2010, 25:2413-2419.
22. Steele J.C., Richardson J.C., Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical supranuclear gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964, 10:333-359.
23. Grimaldi G., Manto M. Topography of cerebellar deficits in humans. Cerebellum 2012, 11:336-351.
24. O'Halloran C.J., Kinsella G.J., Storey E. The cerebellum and neuropsychological functioning: a critical review. J Clin Exp Neuropsychol 2012, 34:35-56.
25. Ghosh B.C., Calder A.J., Peers P.V., Lawrence A.D., Acosta-Cabronero J., Pereira J.M., et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 2012, 135:2089-2102.
26. Schlosser R., Hutchinson M., Joseffer S., Rusinek H., Saarimaki A., Stevenson J. Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatr 1998, 64:492-498.
27. Ackermann H., Wildgruber D., Daum I., Grodd W. Does the cerebellum contribute to cognitive aspects of speech production? A functional magnetic resonance imaging (fMRI) study in humans. Neurosci Lett 1998, 247:187-190.
28. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127:791-800.
29. Bouchard T.P., Malykhin N., Martin W.R., Hanstock C.C., Emery D.J., Fisher N.J., et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 2008, 29:1027-1039.
30. Weintraub D., Doshi J., Koka D. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011, 68:1562-1568.
31. Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J., et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatr 2012, 83:188-194.
32. Bensimon G., Ludolph A., Agid Y., Vidailhet M., Payan C., Leigh P.N. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009, 132:156-171.
33. Josephs K.A., Whitwell J.L., Dickson D.W., Boeve B.F., Knopman D.S., Petersen R.C., et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008, 29:280-289.